297 related articles for article (PubMed ID: 10330423)
1. Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.
Sunyer T; Lewis J; Collin-Osdoby P; Osdoby P
J Clin Invest; 1999 May; 103(10):1409-18. PubMed ID: 10330423
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
3. Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women.
Abrahamsen B; Shalhoub V; Larson EK; Eriksen EF; Beck-Nielsen H; Marks SC
Bone; 2000 Feb; 26(2):137-45. PubMed ID: 10678408
[TBL] [Abstract][Full Text] [Related]
4. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.
Lang D; Knop J; Wesche H; Raffetseder U; Kurrle R; Boraschi D; Martin MU
J Immunol; 1998 Dec; 161(12):6871-7. PubMed ID: 9862719
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptors type I and type II are differentially regulated in human keratinocytes by ultraviolet B radiation.
Grewe M; Gyufko K; Budnik A; Ruzicka T; Olaizola-Horn S; Berneburg M; Krutmann J
J Invest Dermatol; 1996 Dec; 107(6):865-70. PubMed ID: 8941676
[TBL] [Abstract][Full Text] [Related]
6. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
7. IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes.
Pousset F; Cremona S; Dantzer R; Kelley KW; Parnet P
J Neurochem; 2001 Nov; 79(4):726-36. PubMed ID: 11723165
[TBL] [Abstract][Full Text] [Related]
8. Osteoclasts in normal and adjuvant arthritis bone tissues express the mRNA for both type I and II interleukin-1 receptors.
Xu LX; Kukita T; Nakano Y; Yu H; Hotokebuchi T; Kuratani T; Iijima T; Koga T
Lab Invest; 1996 Nov; 75(5):677-87. PubMed ID: 8941213
[TBL] [Abstract][Full Text] [Related]
9. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.
Bossù P; Visconti U; Ruggiero P; Macchia G; Muda M; Bertini R; Bizzarri C; Colagrande A; Sabbatini V; Maurizi G
Am J Pathol; 1995 Dec; 147(6):1852-61. PubMed ID: 7495308
[TBL] [Abstract][Full Text] [Related]
10. Induction of intracellular interleukin-1 beta signals via type II interleukin-1 receptor in human gingival fibroblasts.
Chou HH; Takashiba S; Maeda H; Naruishi K; Nishimura F; Arai H; Lu H; Murayama Y
J Dent Res; 2000 Sep; 79(9):1683-8. PubMed ID: 11023264
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.
Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC
Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930
[TBL] [Abstract][Full Text] [Related]
12. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.
Pacifici R
J Bone Miner Res; 1996 Aug; 11(8):1043-51. PubMed ID: 8854239
[TBL] [Abstract][Full Text] [Related]
13. Regulation of bovine interleukin-1 receptors.
Yu PW; Schuler LA; Rejman JJ; Chen HT; Gosink K; Kehrli M; Mattocks L; Nonnecke B; Czuprynski CJ
Vet Immunol Immunopathol; 1998 May; 63(1-2):21-5. PubMed ID: 9656437
[TBL] [Abstract][Full Text] [Related]
14. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures.
Ramalho AC; Couttet P; Baudoin C; Morieux C; Graulet AM; de Vernejoul MC; Cohen-Solal ME
Eur Cytokine Netw; 2002; 13(1):39-45. PubMed ID: 11956019
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 beta suppresses apoptosis in CD34 positive bone marrow cells through activation of the type I IL-1 receptor.
Rodriguez C; Lacasse C; Hoang T
J Cell Physiol; 1996 Feb; 166(2):387-96. PubMed ID: 8591999
[TBL] [Abstract][Full Text] [Related]
16. Functional genomic analysis of type II IL-1beta decoy receptor: potential for gene therapy in human arthritis and inflammation.
Attur MG; Dave MN; Leung MY; Cipolletta C; Meseck M; Woo SL; Amin AR
J Immunol; 2002 Feb; 168(4):2001-10. PubMed ID: 11823537
[TBL] [Abstract][Full Text] [Related]
17. IL-1 mediates TNF-induced osteoclastogenesis.
Wei S; Kitaura H; Zhou P; Ross FP; Teitelbaum SL
J Clin Invest; 2005 Feb; 115(2):282-90. PubMed ID: 15668736
[TBL] [Abstract][Full Text] [Related]
18. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding.
Cui X; Rouhani FN; Hawari F; Levine SJ
J Immunol; 2003 Dec; 171(12):6814-9. PubMed ID: 14662887
[TBL] [Abstract][Full Text] [Related]
19. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts.
Penton-Rol G; Orlando S; Polentarutti N; Bernasconi S; Muzio M; Introna M; Mantovani A
J Immunol; 1999 Mar; 162(5):2931-8. PubMed ID: 10072543
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo.
Saccani S; Polentarutti N; Penton-Rol G; Sims JE; Mantovani A
Cytokine; 1998 Oct; 10(10):773-80. PubMed ID: 9811530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
